Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and p-aminohippuric acid

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with p-aminohippuric acid in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(p-aminohippuric acid)
Trials
(p-aminohippuric acid)
Recent Studies (post-2010) (p-aminohippuric acid)
9,1561875522,2316488

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)p-aminohippuric acid (IC50)
Solute carrier family 22 member 6Homo sapiens (human)8.8

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brecht, HM; Haberstroh, U; Mihatsch, MJ; Oberle, G; Stahl, RA; Thaiss, F1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and p-aminohippuric acid

ArticleYear
Platelet-activating factor receptor antagonist improves renal function and glomerular lesions in renal ablation.
    The Journal of laboratory and clinical medicine, 1994, Volume: 124, Issue:6

    Topics: Albuminuria; Animals; Azepines; Blood Pressure; Body Weight; Eicosanoids; Inulin; Kidney; Kidney Glomerulus; Male; Nephrectomy; Organ Size; p-Aminohippuric Acid; Platelet Activating Factor; Rats; Rats, Wistar; Triazoles

1994